A new research perspective titled "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma" has been published in Oncotarget.
Feb 7, 2024
0
1
Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails—it can also design new drugs to treat disease.
Feb 7, 2024
0
174
Italian scientists from Università Cattolica at Rome have discovered an important genetic mechanism that pancreatic cancer cells employ to evade therapies, paving the way to new drugs for a killer disease. The tumor evades ...
Feb 6, 2024
0
137
Most new prescription drugs are sold first in the U.S. before they reach other nations, but ultimately important medications are sold across most wealthy nations within about a year of first sale, according to a new RAND ...
Feb 1, 2024
0
1
As a scientist who investigates hunger and weight control, I'm interested in the way our brains let us know we've had enough.
Jan 28, 2024
0
25
Interest in psychedelics is surging, fueled by growing research suggesting they have a place in treatment of conditions like depression and post-traumatic stress disorder. But regulatory challenges loom.
Jan 25, 2024
0
1
Before new drugs are launched on the market they are tested in clinical studies in which one group of study participants often receives the new treatment and another group receives the current standard treatment. The results ...
Jan 24, 2024
0
0
With the life-saving, COVID-fighting drug Paxlovid no longer covered by the federal government, a push is underway in Albany to ensure New Yorkers seeking the medication do not get gouged by pricey co-payments.
Jan 23, 2024
0
0
With several drug overdoses already this season, and recent news of three new recreational drugs identified by the drug checking service in Canberra, many parents of teenagers will be wondering how they can keep their kids ...
Jan 22, 2024
0
1
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
Jan 11, 2024
0
10
